Muscular Dystrophies D009136

Diseases [C] » Musculoskeletal Diseases [C05] » Muscular Diseases » Muscular Disorders, Atrophic » Muscular Dystrophies

Diseases [C] » Nervous System Diseases [C10] » Neuromuscular Diseases » Muscular Diseases » Muscular Disorders, Atrophic » Muscular Dystrophies

Description

A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS.   MeSH

Subtype Terms (9)

Distal Myopathies
 

Glycogen Storage Disease Type VII
1 approved drug

Muscular Dystrophies, Limb-Girdle
12 drugs (3 approved, 9 experimental)

Muscular Dystrophy, Duchenne
91 drugs (38 approved, 53 experimental)

Muscular Dystrophy, Emery-Dreifuss
 

Muscular Dystrophy, Facioscapulohumeral
11 drugs (5 approved, 6 experimental)

Muscular Dystrophy, Oculopharyngeal
3 drugs (1 approved, 2 experimental)

Myotonic Dystrophy
13 drugs (6 approved, 7 experimental)

Walker-Warburg Syndrome
 


Phase 4 Indicated Drugs (2)


Organization Involved with Phase 3 Indications (60)

Organization Involved with Phase 2 Indications (61)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.